Valuation check: EARS's profit margin is 4482.79%, above the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2023
Trailing 12 months ending Jun 2023
Auris Medical Holding (EARS) currently reports a profit margin of 4482.79% as of June 2023. That compares with -2810.27% in the prior-year period — up 259.5% year over year. That is above the Healthcare sector average of 14.34%. Use the charts on this page to explore Auris Medical Holding's profit margin history and peer comparisons.
Auris Medical Holding's profit margin increased from -2810.27% to 4482.79% — a 259.5% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Auris Medical Holding's profit margin of 4482.79% is higher than the Healthcare sector average of 14.34%. That is roughly 31150.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Auris Medical Holding's current 4482.79% should be judged against Healthcare norms (sector average: 14.34%) and against EARS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 4482.79%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Auris Medical Holding, and consider following EARS for alerts when major investors trade the stock.